🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10,225 results for “He” Clear

  1. semaglutide combined with metformin

    The First People's Hospital of Lianyungang

    Osteoporosis

    approved small molecule active

    1 trial

  2. sodium iodide

    United Therapeutics Europe Ltd

    Transient Hypothyroxinemia

    approved small molecule completed

    1 trial

  3. sodium zirconium cyclic silicate

    The First People's Hospital of Lianyungang

    Potassium Imbalance

    approved small molecule active

    1 trial

  4. tasimelteon 20 mg capsule

    Vanda Pharmaceuticals Netherlands B.V.

    Non-24-Hour-Sleep-Wake Disorder

    approved small molecule completed

    1 trial

  5. telbivudine (ROADMAP)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule active

    1 trial

  6. telmisartan

    Boehringer Ingelheim

    Hypertension

    approved small molecule completed

    1 trial

  7. theophylline

    Takeda

    Healthy

    approved small molecule completed

    1 trial

  8. ticagrelor

    The First People's Hospital of Lianyungang

    Inflammation

    approved small molecule completed

    1 trial

  9. tiotropium 18 mcg

    Boehringer Ingelheim

    Pulmonary Disease, Chronic Obstructive

    approved small molecule completed

    1 trial

  10. tong-jiang granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome

    approved small molecule active

    1 trial

  11. transdermal nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule active

    1 trial

  12. trastuzumab [Herceptin]

    Hoffmann-La Roche

    Gastric Cancer

    approved small molecule terminated

    1 trial

  13. treprostinil sodium

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    1 trial

  14. treprostinil sodium

    United Therapeutics Europe Ltd

    Hypertension, Pulmonary

    approved small molecule terminated

    2 trials

  15. treprostinil sodium

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    approved small molecule completed

    1 trial

  16. umeclidinium 62.5 µg and vilanterol 25 µg

    Theravance Biopharma Ireland Umited

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule active

    1 trial

  17. 18F-FDG

    The First People's Hospital of Lianyungang

    Tumor, Solid

    other completed

    1 trial

  18. 2 mg hydromorphone

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    small molecule completed

    1 trial

  19. 20 grams protein

    United Therapeutics Europe Ltd

    Muscle Disuse

    other active

    1 trial

  20. 24/7 EEG™ SubQ

    COGNITION THERAPEUTICS INC

    Sleep

    other completed

    1 trial

  21. 3T MR Imaging of the cervical spinal cord

    United Therapeutics Europe Ltd

    Cervical Spondylosis With Myelopathy

    other active

    1 trial

  22. 4D

    4D Molecular Therapeutics

    Dietary Supplementation

    other completed

    1 trial

  23. 68Ga-DOTA-NT-20.3

    The First People's Hospital of Lianyungang

    Pancreatic Ductal Adenocarcinoma

    other completed

    1 trial

  24. 68Ga-Her2-affibody

    The First People's Hospital of Lianyungang

    Neoplasms

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources